Home > Products > Nkp46 & CD30 > Recombinant Human Anti-Nkp46 x Mouse Anti-CD30 Bispecific Antibody (Tandem Fab)

Recombinant Human Anti-Nkp46 x Mouse Anti-CD30 Bispecific Antibody (Tandem Fab)  (CAT#: KN-0725-N75)

Recombinant Human Anti-Nkp46 x Mouse Anti-CD30 Bispecific Antibody (Tandem Fab) is designed to be expressed as three chains derived from the variable domains of anti-Nkp46 and anti-CD30 parental antibodies. It contains a His-tag for affinity purification. And the two Fd regions are connected by a flexible linker. This BsAb can retarget NK cells to tumor cells. It is designed for the research of Neuroblastoma; Osteosarcoma; Hodgkin lymphoma; T cell lymphoma; Anaplastic large cell lymphoma (ALCL) therapy.
Datasheet INQUIRY

Specifications

Targets
Nkp46 & CD30
Type
Tandem Fab
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Neuroblastoma; Osteosarcoma; Hodgkin lymphoma; T cell lymphoma; Anaplastic large cell lymphoma (ALCL)
Host Animal 1
Human
Host Animal 2
Mouse

Targets

Target 1
Nkp46
Gene ID
UniProt ID
Alternative Names
CD335; NCR1; Natural Cytotoxicity Triggering Receptor 1, gene symbol; NK-p46; Natural Killer Cell Activating Receptor p46; LY94; CD335; NKP46; NK-p46; Natural cytotoxicity triggering receptor 1; Lymphocyte antigen 94 homolog; NK cell-activating receptor; Natural killer cell p46-related protein; NCR1
Target 2
CD30
Gene ID
UniProt ID
Alternative Names
TNFRSF8; tumor necrosis factor receptor superfamily, member 8; CD30; Ki-1; D1S166E; tumor necrosis factor receptor superfamily member 8; Ki-1 antigen; CD30L receptor; cytokine receptor CD30; lymphocyte activation antigen CD30
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-Nkp46 x Mouse Anti-CD30 Bispecific Antibody (Tandem Fab) (KN-0725-N75). Click the button below to contact us or submit your feedback about this product.